Karin Rosen

Director/Board Member at DIAMYD MEDICAL AB

Net worth: 1 211 $ as of 2026-05-30

59 year

Health Technology

Consumer Services

Profile

Currently, Karin Rosen holds the position of Chief Scientific Officer of Horizon Therapeutics Plc. In her past career Dr. Rosen held the position of Senior Vice President-US Medical Affairs at GlaxoSmithKline Plc. She received a doctorate from the University of Lund.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
DIAMYD MEDICAL AB CLASS B 0.01%	2025-08-30	10,000 ( 0.01% )	1 211 $	2026-05-30

Karin Rosen active positions

Companies	Position	Start
DIAMYD MEDICAL AB	Director/Board Member	2023-03-09

All active positions of Karin Rosen

Former positions of Karin Rosen

Companies	Position	End
GSK PLC	Corporate Officer/Principal	2020-10-31
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY	Chief Tech/Sci/R&D Officer	-

See the detail of Karin Rosen's experience

Training of Karin Rosen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Karin Rosen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Horizon Therapeutics Ltd. (Ireland) Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	Health Technology
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
University of Lund University of Lund Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Diamyd Medical AB Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes	Health Technology